Company intelligence / Profile preview

Euv Biologics

Seoul, South Korea
Ownership
Private
Employees
~250
Development stage
Other
01

Overview

EuBiologics is a South Korean biotechnology company specializing in the development and commercialization of vaccines for infectious diseases. The company is a leading global supplier of oral cholera vaccines, including Euvichol and Euvichol-Plus, which are prequalified by the World Health Organization and distributed via UNICEF. EuBiologics utilizes its proprietary EuVCT (Vaccine Conjugation Technology) and EuIMT (Immune Modulator Technology) platforms to develop a robust pipeline, including candidates for typhoid, meningococcal meningitis, COVID-19, and RSV. In addition to its internal R&D, the company operates large-scale manufacturing facilities in Chuncheon and provides CDMO services for biological products. EuBiologics maintains strategic collaborations with international organizations such as the Bill & Melinda Gates Foundation and the International Vaccine Institute to address global health challenges.

Therapeutic areas
Infectious Diseases
Modalities
VaccineRecombinant proteinConjugate vaccine
Industry
Biotech
02

Partnerships

International Vaccine Institute (IVI)Bill & Melinda Gates FoundationPATHUNICEFGavi, the Vaccine Alliance

Beyond the preview

Go deeper on Euv Biologics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Euv Biologics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call